Financials of Alembic Pharmaceuticals Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Alembic Pharmaceuticals Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +1,4061,4861,5951,6311,5171,5621,6481,6931,7701,7111,9101,8761,848
Expenses +1,2031,2871,3871,3641,2571,3251,4091,4331,4981,4301,5941,5851,620
Operating Profit204199208266260237239260271281316292228
OPM %14%13%13%16%17%15%15%15%15%16%17%16%12%
Other Income +1121034230101468-272
Interest14141615111319222524242323
Depreciation74666869696971706974768089
Profit before tax116130135185183157180178192190224162119
Tax %-31%7%-1%2%3%14%15%23%18%19%18%18%-70%
Net Profit +153121137180178135153138157154184132202
EPS in Rs7.766.146.959.189.076.857.807.047.987.859.406.7610.31

Financials of Alembic Pharmaceuticals Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2,0563,1663,1053,1313,9354,6065,3935,3065,6536,2296,6727,345
Expenses +1,6532,1592,4902,4883,0613,3833,9134,4324,9705,2965,6646,226
Operating Profit4031,0076156438741,2231,4808746829321,0081,118
OPM %20%32%20%21%22%27%27%16%12%15%15%15%
Other Income +47279-398756-22856-12
Interest45531827161850567994
Depreciation447283105115157183287275273279319
Profit before tax3599365295417491,0001,368625355632707694
Tax %21%23%23%22%21%20%19%17%4%3%18%3%
Net Profit +2837204034135838011,146521342616582671
EPS in Rs15.0138.2021.3921.8931.0043.9758.3326.5017.4031.3329.6834.33
Dividend Payout %23%9%19%18%18%23%24%38%46%35%37%35%

Financials of Alembic Pharmaceuticals Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital383838383838393939393939
Reserves8471,5601,8652,1822,6813,1825,0285,1984,3314,7795,1525,636
Borrowings +264114897081,1281,7475847177225131,2581,430
Other Liabilities +4937186981,0139311,0221,0581,1671,0901,1141,3241,658
Total Liabilities1,6412,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,763
Fixed Assets +5477087999931,1581,5521,7881,7982,3982,5472,5243,130
CWIP83933961,0101,5511,8462,1832,304601524837634
Investments287504249182361189693127141
Other Assets +1,0091,5411,4441,8962,0192,5732,5022,9023,0873,2814,2854,858
Total Assets1,6412,4292,6893,9414,7785,9896,7097,1226,1836,4467,7738,763

Financials of Alembic Pharmaceuticals Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +1729483293128124491,46355272480388783
Cash from Investing Activity +-256-307-486-884-756-731-840-372-448-321-568-506
Cash from Financing Activity +87-224-12950359155-597-217-262-438444-164
Net Cash Flow3417-286-69115-12726-371445-37113
Free Cash Flow-52647348-49549-285804128282487-466290
CFO/OP60%114%73%70%112%56%115%77%115%88%16%79%

Financials of Alembic Pharmaceuticals Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days644040614569245668607773
Inventory Days196266269302356417431406315350466462
Days Payable166264213313237220194178145157179154
Cash Conversion Cycle94429651164266261283237253363381
Working Capital Days323661692450737477888788
ROCE %38%66%29%22%23%24%26%11%7%13%13%13%